SI-BONE, Inc. (SIBN) Income Statement
SIBN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSIBN revenue and net income
Where SIBN's revenue goes
2025Each bar shows an amount and its share of revenue. SIBN kept −9.4% of revenue as net income.
SIBN profit margins
SIBN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +20.2% | +23.6% | +22.3% | +17.2% |
| Gross profit | +21.0% | +20.8% | +19.9% | +16.2% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SIBN quarterly EPS vs estimates
SI-BONE beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 9, 2026 (estimate $-0.13).
SIBN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $200.9M | $167.2M | $138.9M | $106.4M | $90.2M | $73.4M | $67.3M | $55.4M | $48.0M | $42.1M |
| Cost of revenue | $41.0M | $35.1M | $29.5M | $15.7M | $10.4M | $8.9M | $6.8M | $4.8M | $5.1M | $5.2M |
| Gross profit | $159.9M | $132.1M | $109.4M | $90.7M | $79.7M | $64.5M | $60.5M | $50.5M | $42.9M | $36.9M |
| Research & development | $17.4M | $16.6M | $15.0M | $13.6M | $12.4M | $9.5M | $7.3M | $5.4M | $5.5M | $6.4M |
| Sales, general & admin | $164.8M | $150.8M | $141.3M | $136.7M | $119.0M | $93.6M | $89.2M | $57.1M | $54.7M | $48.1M |
| Total operating expenses | $182.2M | $167.4M | $156.4M | $150.3M | $131.4M | $103.1M | $96.5M | $62.5M | $60.2M | $54.5M |
| Operating income | −$22.3M | −$35.2M | −$46.9M | −$59.6M | −$51.7M | −$38.6M | −$36.0M | −$12.0M | −$17.4M | −$17.6M |
| Interest income | $6.1M | $7.8M | $5.4M | $1.3M | $186,000 | $1.1M | $2.6M | $769,000 | $175,000 | $71,000 |
| Interest expense | $5.3M | $3.4M | $3.5M | $2.8M | $5.4M | $6.1M | $4.9M | $5.5M | $6.2M | $3.3M |
| Income before taxes | −$18.9M | −$30.9M | −$43.3M | −$61.3M | −$56.6M | −$43.7M | −$38.4M | −$17.5M | −$23.0M | −$20.6M |
| Income taxes | — | — | $5.3M | $1.6M | $3.6M | $4.8M | $4.2M | $5.5M | $5.7M | $3.0M |
| Net income | −$18.9M | −$30.9M | −$43.3M | −$61.3M | −$56.6M | −$43.7M | −$38.4M | −$17.5M | −$23.0M | −$20.6M |
| EBITDA | −$10.9M | −$23.1M | −$34.4M | −$55.0M | −$51.0M | −$36.5M | −$32.7M | −$11.2M | −$15.8M | −$16.2M |
| EPS (diluted) | −$0.44 | −$0.76 | −$1.14 | −$1.79 | −$1.70 | −$1.52 | −$1.55 | −$1.01 | −$1.47 | −$6.30 |
| Gross margin | 79.6% | 79.0% | 78.8% | 85.2% | 88.4% | 87.9% | 89.9% | 91.3% | 89.3% | 87.7% |
| Operating margin | −11.1% | −21.1% | −33.8% | −56.0% | −57.3% | −52.6% | −53.5% | −21.6% | −36.2% | −41.7% |
| Net margin | −9.4% | −18.5% | −31.2% | −57.6% | −62.8% | −59.5% | −57.1% | −31.5% | −48.0% | −48.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $56.0M | $52.6M | $56.4M | $48.7M | $48.6M | $47.3M | $49.0M | $40.3M | $40.0M | $37.9M | $38.9M | $34.0M |
| Cost of revenue | $11.5M | $10.6M | $11.8M | $9.8M | $9.8M | $9.6M | $10.2M | $8.4M | $8.4M | $8.0M | $10.2M | $7.0M |
| Gross profit | $44.5M | $41.9M | $44.5M | $38.8M | $38.8M | $37.7M | $38.8M | $31.9M | $31.6M | $29.9M | $28.7M | $27.0M |
| Research & development | $5.2M | $4.2M | $4.4M | $4.2M | $4.3M | $4.5M | $3.9M | $4.0M | $4.4M | $4.3M | $4.2M | $3.9M |
| Sales, general & admin | $44.1M | $42.8M | $42.6M | $40.0M | $41.5M | $40.6M | $40.4M | $35.5M | $37.3M | $37.6M | $37.0M | $34.2M |
| Total operating expenses | $49.4M | $47.0M | $47.0M | $44.2M | $45.8M | $45.2M | $44.3M | $39.5M | $41.7M | $41.9M | $41.2M | $38.1M |
| Operating income | −$4.8M | −$5.1M | −$2.5M | −$5.4M | −$7.0M | −$7.5M | −$5.5M | −$7.6M | −$10.1M | −$12.0M | −$12.5M | −$11.2M |
| Interest income | $1.3M | $1.4M | $1.4M | $1.5M | $1.5M | $1.6M | $1.8M | $1.9M | $2.0M | $2.1M | $2.2M | $2.2M |
| Interest expense | $598,000 | $592,000 | $629,000 | $670,000 | $666,000 | $662,000 | $793,000 | $884,000 | $880,000 | $881,000 | $890,000 | $884,000 |
| Income before taxes | −$4.1M | −$4.3M | −$1.6M | −$4.6M | −$6.2M | −$6.5M | −$4.5M | −$6.6M | −$8.9M | −$10.9M | −$11.0M | −$10.0M |
| Income taxes | — | — | — | — | — | — | — | — | — | $1.0M | $3.0M | −$1.3M |
| Net income | −$4.1M | −$4.3M | −$1.6M | −$4.6M | −$6.2M | −$6.5M | −$4.5M | −$6.6M | −$8.9M | −$10.9M | −$11.0M | −$10.0M |
| EBITDA | −$3.1M | −$2.1M | $2.7M | −$2.4M | −$4.1M | −$4.6M | −$2.5M | −$4.6M | −$7.1M | −$8.9M | −$8.5M | −$7.6M |
| EPS (diluted) | −$0.09 | −$0.10 | −$0.04 | −$0.11 | −$0.14 | −$0.15 | −$0.11 | −$0.16 | −$0.22 | −$0.27 | −$0.27 | −$0.25 |
| Gross margin | 79.5% | 79.8% | 79.0% | 79.8% | 79.8% | 79.7% | 79.1% | 79.1% | 79.0% | 78.9% | 73.8% | 79.3% |
| Operating margin | −8.6% | −9.7% | −4.4% | −11.1% | −14.4% | −15.8% | −11.2% | −18.9% | −25.2% | −31.8% | −32.2% | −32.8% |
| Net margin | −7.3% | −8.2% | −2.9% | −9.4% | −12.7% | −13.8% | −9.2% | −16.3% | −22.4% | −28.8% | −28.3% | −29.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SIBN's financial statements (latest annual report filed February 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SIBN financial results
In fiscal year 2025 (ended December 31, 2025), SI-BONE reported revenue of $200.9 million, up 20.2% from the year before. It had a net loss of $18.9 million, a net profit margin of −9.4%. Diluted earnings per share came to −$0.44. Over five years revenue grew at an average rate of 22.3% a year.
See the SIBN stock overview for the latest quote and news, or the SIBN chart for price history and technical indicators.
SIBN income statement FAQ
What is SI-BONE's annual revenue?
SI-BONE reported total revenue of $200.9 million for fiscal year 2025, which ended on December 31, 2025. That was up 20.2% from $167.2 million the previous year.
Is SI-BONE profitable?
No. SI-BONE reported a net loss of $18.9 million in fiscal 2025, a net profit margin of −9.4%; its operating margin was −11.1%.
What is SI-BONE's gross margin?
SI-BONE's gross margin was 79.6% in fiscal 2025: for every $100 of revenue, SI-BONE kept $80 after the direct cost of its products and services.
How much does SI-BONE spend on research and development?
SI-BONE spent $17.4 million on research and development in fiscal 2025, 8.7% of revenue.
How fast is SI-BONE growing?
Revenue grew 22.3% a year on average over the last five fiscal years, from $73.4 million to $200.9 million.
What are SI-BONE's earnings per share?
SI-BONE earned $-0.44 per diluted share in fiscal 2025, compared with $-0.76 a year earlier.
When will SI-BONE report its next earnings?
SI-BONE is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes.
When does SI-BONE's fiscal year end?
SI-BONE's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 24, 2026.